Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Homocysteine and serum markers of immune activation in primary dystonia.

Identifieur interne : 001397 ( Ncbi/Checkpoint ); précédent : 001396; suivant : 001398

Homocysteine and serum markers of immune activation in primary dystonia.

Auteurs : Ulf J. Muller [Autriche] ; Barbara Frick ; Christiana Winkler ; Dietmar Fuchs ; Gregor K. Wenning ; Werner Poewe [Autriche] ; Joerg Mueller

Source :

RBID : pubmed:16108020

English descriptors

Abstract

The cause of primary dystonia remains unknown. Several reports point to immune system disturbances in primary dystonia and a recent study demonstrated hyperhomocysteinemia in cervical dystonia. Homocysteine (HCY) is an amino acid and elevated HCY concentrations were shown to be associated with immune system activation and increased neopterin serum concentrations. We examined HCY serum concentrations together with serum markers of immune activation in patients with different types of primary dystonia. Eighty-three patients with different types of primary dystonia were included and investigated at least 3 months following botulinum toxin treatment. Thirty-six healthy volunteers with similar age and sex distribution served as controls. Total serum HCY, kynurenine, and tryptophan concentrations were determined by high-performance liquid chromatography; neopterin, folate, and vitamin B12 concentrations were measured by immunoassays. Routine blood analysis, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood count (WBC), was performed. Patients with primary dystonia had significantly higher HCY concentrations compared to controls. Among the dystonia subtypes, no significant difference of HCY serum concentrations was observed. CRP and ESR were within the normal range in >90% of the patients and all had normal WBC. Neopterin, kynurenine, and tryptophan serum concentrations were similar in patients and controls and not correlated with HCY serum concentrations. The results provide evidence against enhanced cellular immune activation in patients with primary dystonia. However, hyperhomocysteinemia was present in all dystonia subtypes and unrelated to immune activation in this study. HCY is a neuronal excitotoxic amino acid and hyperhomocysteinemia is considered an independent vascular risk factor. Further studies are required to define the background of hyperhomocysteinemia in primary dystonia.

DOI: 10.1002/mds.20667
PubMed: 16108020


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16108020

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Homocysteine and serum markers of immune activation in primary dystonia.</title>
<author>
<name sortKey="Muller, Ulf J" sort="Muller, Ulf J" uniqKey="Muller U" first="Ulf J" last="Muller">Ulf J. Muller</name>
<affiliation wicri:level="1">
<nlm:affiliation>University Hospital of Neurology, Medical University Innsbruck, Innsbruck, Austria. joerg.mueller@uibk.ac.at</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>University Hospital of Neurology, Medical University Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Frick, Barbara" sort="Frick, Barbara" uniqKey="Frick B" first="Barbara" last="Frick">Barbara Frick</name>
</author>
<author>
<name sortKey="Winkler, Christiana" sort="Winkler, Christiana" uniqKey="Winkler C" first="Christiana" last="Winkler">Christiana Winkler</name>
</author>
<author>
<name sortKey="Fuchs, Dietmar" sort="Fuchs, Dietmar" uniqKey="Fuchs D" first="Dietmar" last="Fuchs">Dietmar Fuchs</name>
</author>
<author>
<name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mueller, Joerg" sort="Mueller, Joerg" uniqKey="Mueller J" first="Joerg" last="Mueller">Joerg Mueller</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="doi">10.1002/mds.20667</idno>
<idno type="RBID">pubmed:16108020</idno>
<idno type="pmid">16108020</idno>
<idno type="wicri:Area/PubMed/Corpus">002F15</idno>
<idno type="wicri:Area/PubMed/Curation">002F15</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003107</idno>
<idno type="wicri:Area/Ncbi/Merge">001397</idno>
<idno type="wicri:Area/Ncbi/Curation">001397</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001397</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Homocysteine and serum markers of immune activation in primary dystonia.</title>
<author>
<name sortKey="Muller, Ulf J" sort="Muller, Ulf J" uniqKey="Muller U" first="Ulf J" last="Muller">Ulf J. Muller</name>
<affiliation wicri:level="1">
<nlm:affiliation>University Hospital of Neurology, Medical University Innsbruck, Innsbruck, Austria. joerg.mueller@uibk.ac.at</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>University Hospital of Neurology, Medical University Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Frick, Barbara" sort="Frick, Barbara" uniqKey="Frick B" first="Barbara" last="Frick">Barbara Frick</name>
</author>
<author>
<name sortKey="Winkler, Christiana" sort="Winkler, Christiana" uniqKey="Winkler C" first="Christiana" last="Winkler">Christiana Winkler</name>
</author>
<author>
<name sortKey="Fuchs, Dietmar" sort="Fuchs, Dietmar" uniqKey="Fuchs D" first="Dietmar" last="Fuchs">Dietmar Fuchs</name>
</author>
<author>
<name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mueller, Joerg" sort="Mueller, Joerg" uniqKey="Mueller J" first="Joerg" last="Mueller">Joerg Mueller</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Biological Markers (blood)</term>
<term>Botulinum Toxins (therapeutic use)</term>
<term>C-Reactive Protein (metabolism)</term>
<term>Chromatography, High Pressure Liquid (methods)</term>
<term>Dystonic Disorders (blood)</term>
<term>Dystonic Disorders (classification)</term>
<term>Dystonic Disorders (drug therapy)</term>
<term>Dystonic Disorders (immunology)</term>
<term>Female</term>
<term>Folic Acid (blood)</term>
<term>Follow-Up Studies</term>
<term>Homocysteine (blood)</term>
<term>Humans</term>
<term>Immunity (drug effects)</term>
<term>Immunity (physiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Vitamin B 12 (blood)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Biological Markers</term>
<term>Folic Acid</term>
<term>Homocysteine</term>
<term>Vitamin B 12</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>C-Reactive Protein</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Immunity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Dystonic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Chromatography, High Pressure Liquid</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Immunity</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The cause of primary dystonia remains unknown. Several reports point to immune system disturbances in primary dystonia and a recent study demonstrated hyperhomocysteinemia in cervical dystonia. Homocysteine (HCY) is an amino acid and elevated HCY concentrations were shown to be associated with immune system activation and increased neopterin serum concentrations. We examined HCY serum concentrations together with serum markers of immune activation in patients with different types of primary dystonia. Eighty-three patients with different types of primary dystonia were included and investigated at least 3 months following botulinum toxin treatment. Thirty-six healthy volunteers with similar age and sex distribution served as controls. Total serum HCY, kynurenine, and tryptophan concentrations were determined by high-performance liquid chromatography; neopterin, folate, and vitamin B12 concentrations were measured by immunoassays. Routine blood analysis, including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood count (WBC), was performed. Patients with primary dystonia had significantly higher HCY concentrations compared to controls. Among the dystonia subtypes, no significant difference of HCY serum concentrations was observed. CRP and ESR were within the normal range in >90% of the patients and all had normal WBC. Neopterin, kynurenine, and tryptophan serum concentrations were similar in patients and controls and not correlated with HCY serum concentrations. The results provide evidence against enhanced cellular immune activation in patients with primary dystonia. However, hyperhomocysteinemia was present in all dystonia subtypes and unrelated to immune activation in this study. HCY is a neuronal excitotoxic amino acid and hyperhomocysteinemia is considered an independent vascular risk factor. Further studies are required to define the background of hyperhomocysteinemia in primary dystonia.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Autriche</li>
</country>
<region>
<li>Tyrol (Land)</li>
</region>
<settlement>
<li>Innsbruck</li>
</settlement>
<orgName>
<li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Frick, Barbara" sort="Frick, Barbara" uniqKey="Frick B" first="Barbara" last="Frick">Barbara Frick</name>
<name sortKey="Fuchs, Dietmar" sort="Fuchs, Dietmar" uniqKey="Fuchs D" first="Dietmar" last="Fuchs">Dietmar Fuchs</name>
<name sortKey="Mueller, Joerg" sort="Mueller, Joerg" uniqKey="Mueller J" first="Joerg" last="Mueller">Joerg Mueller</name>
<name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K" last="Wenning">Gregor K. Wenning</name>
<name sortKey="Winkler, Christiana" sort="Winkler, Christiana" uniqKey="Winkler C" first="Christiana" last="Winkler">Christiana Winkler</name>
</noCountry>
<country name="Autriche">
<noRegion>
<name sortKey="Muller, Ulf J" sort="Muller, Ulf J" uniqKey="Muller U" first="Ulf J" last="Muller">Ulf J. Muller</name>
</noRegion>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001397 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001397 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:16108020
   |texte=   Homocysteine and serum markers of immune activation in primary dystonia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:16108020" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024